Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL) Meeting Abstract

  

Authors:	Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I. K.; Deangelis, L.
Abstract Title:	Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
Meeting Title:	41st European Society for Medical Oncology Congress (ESMO)
Journal Title:	Annals of Oncology
Volume:	27
Issue:	Suppl. 6
Meeting Dates:	2016 Oct 7-11
Meeting Location:	Copenhagen, Denmark
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2016-10-01
Start Page:	vi105
Language:	English
ACCESSION:	WOS:000393912500330
DOI:	10.1093/annonc/mdw367.09
PROVIDER:	wos
Notes:	Meeting Abstract: 331PD -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/109015